You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/12053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOliveira, Joao Batista A.-
dc.contributor.authorMauri, Ana Lucia-
dc.contributor.authorPetersen, Claudia G.-
dc.contributor.authorMartins, Anice M. C.-
dc.contributor.authorCornicelli, Joao-
dc.contributor.authorCavanha, Mario-
dc.contributor.authorPontes, Anaglória-
dc.contributor.authorBaruffi, Ricardo L. R.-
dc.contributor.authorFranco, Jose G.-
dc.date.accessioned2014-05-20T13:35:06Z-
dc.date.accessioned2016-10-25T16:52:35Z-
dc.date.available2014-05-20T13:35:06Z-
dc.date.available2016-10-25T16:52:35Z-
dc.date.issued2007-03-01-
dc.identifierhttp://dx.doi.org/10.1007/s10815-006-9095-4-
dc.identifier.citationJournal of Assisted Reproduction and Genetics. New York: Springer/plenum Publishers, v. 24, n. 2-3, p. 67-75, 2007.-
dc.identifier.issn1058-0468-
dc.identifier.urihttp://hdl.handle.net/11449/12053-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/12053-
dc.description.abstractPurpose: to compare the efficacy of recombinant LH supplementation for controlled ovarian stimulation in recombinant FSH and GnRH-agonist protocol.Methods: Search strategies included on-line surveys of databases. The fixed effects model was used for odds ratio and effect size (weighted mean difference). Four trials fulfilled the inclusion criteria.Results: a fewer days of stimulation (p < 0.0001), a fewer total amount of r-FSH administered (p < 0.0001) and a higher serum estradiol levels on the day of hCG administration (p < 0.0001) were observed for the r-LH supplementation protocol. However, differences were not observed in number of oocyte retrieved, number of mature oocytes, clinical pregnancy per oocyte retrieval, implantation and miscarriage rates.Conclusions: more randomized controlled trials are necessary before evidence-based recommendations regarding exogenous LH supplementation in ovarian stimulation protocols with FSH and GnRH-agonist for assisted reproduction treatment can be provided.en
dc.format.extent67-75-
dc.language.isoeng-
dc.publisherSpringer-
dc.sourceWeb of Science-
dc.subjectGnRH agonistpt
dc.subjectrecombinant FSHpt
dc.subjectrecombinant LHpt
dc.subjectovarian stimulationpt
dc.titleRecombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: A meta-analysisen
dc.typeoutro-
dc.contributor.institutionCtr Human Reprod Prof Franco Jr-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationCtr Human Reprod Prof Franco Jr, Ribeirao Preto, SP, Brazil-
dc.description.affiliationUNESP, Fac Med Botucatu, Dept Gynecol & Obstet, Botucatu, SP, Brazil-
dc.description.affiliationUniv Santo Amaro, Fac Med, São Paulo, Brazil-
dc.description.affiliationUnespUNESP, Fac Med Botucatu, Dept Gynecol & Obstet, Botucatu, SP, Brazil-
dc.identifier.doi10.1007/s10815-006-9095-4-
dc.identifier.wosWOS:000245534400006-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofJournal of Assisted Reproduction and Genetics-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.